The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125630241 12563024 1 I 20160630 20160704 20160715 20160715 EXP BR-ELI_LILLY_AND_COMPANY-BR201607001198 ELI LILLY AND CO 0.00 F Y 0.00000 20160715 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125630241 12563024 1 PS CYMBALTA DULOXETINE HYDROCHLORIDE 1 Oral 30 MG, QD N C529639 21427 30 MG CAPSULE QD
125630241 12563024 2 SS CYMBALTA DULOXETINE HYDROCHLORIDE 1 N 21427 CAPSULE
125630241 12563024 3 C RIVOTRIL CLONAZEPAM 1 Unknown 2 MG, EACH EVENING U 0 2 MG QD
125630241 12563024 4 C LAMITOR LAMOTRIGINE 1 Unknown UNK, QD U 0 QD
125630241 12563024 5 C DORFLEX CAFFEINEDIPYRONEORPHENADRINE 1 Unknown UNK, QD U 0 QD
125630241 12563024 6 C CYCLOBENZAPRINE CYCLOBENZAPRINE 1 Unknown 10 MG, QD U 0 10 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125630241 12563024 1 Depression
125630241 12563024 2 Spinal pain
125630241 12563024 3 Insomnia
125630241 12563024 4 Affective disorder
125630241 12563024 6 Headache

Outcome of event

Event ID CASEID OUTC COD
125630241 12563024 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125630241 12563024 Aphasia
125630241 12563024 Bruxism
125630241 12563024 Disturbance in attention
125630241 12563024 Dysphemia
125630241 12563024 Emotional disorder
125630241 12563024 Headache
125630241 12563024 Hunger
125630241 12563024 Insomnia
125630241 12563024 Memory impairment
125630241 12563024 Nightmare
125630241 12563024 Tachycardia
125630241 12563024 Vision blurred
125630241 12563024 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125630241 12563024 1 20160630 20160704 0